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aminophen is described. The method is based on the hydrolysis of the cephalosporin in sodium
hydroxide solution to produce the sulphide ion and the conversion of the sulphide with the p-phen-
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Cephalosporins are a group of b-lactam antibiotics and are
extensively employed as bacteriostatic antibiotic drugs. Various
methods for their determination have been reviewed. These
methods include the biological methods (Fogg and Abdalla,
1985) which are very elaborate and not suitable for routine anal-
ysis. Other methods include spectrophotometry (Abdalla et al.,
1982a,b; Fogg and Abdalla, 1982; Abdalla, 1991; Issopoulos,(Z.A. ALOthman).
y. Production and hosting by
Saud University.
lsevier1989; Bundgaard, 1977), ﬂuorimetry, (Barbahaiya and Tuner,
1976, 1977; Tusji et al., 1978) electrochemistry (Squella et al.,
1981; Fayed, 1979) and titrimetry (Alicino, 1976; Pharmaco-
poeia, 1980; Kramer and Tolentino, 1999; Mohamed, 1997).
The majority of these methods suffer from lengthy treatment
and lack of suitability for routine analysis.
Oxidative coupling of p-phenylenediamine with phenols for
the determination of either the diamine or the phenols has been
described in the literature. Kramer and Tolentino (Kramer and
Tolentino, 1999) have described a method for the determina-
tion of phenol, 2,6-xylenol using N,N-dimethyl-p-phenylenedi-
amine and a mixture of potassium dichromate and potassium
ferricyanide. The use of N,N-diethyl-p-phenylene diamine was
found to give better result than the N,N-dimethyl derivatives.
The present work is based on the oxidative coupling of
p-phenylenediamine with the hydrogen sulphide that is repro-
ducibly obtained from the alkaline degradation of cephalospo-
rin antibiotics and iron(III). All of the cephalosporins studied
gave a reproducible yield of sulphide when they degraded in a
0.5 M sodium hydroxide solution in boiling water bath. The
Table 1 Structure of Cephalosporins and Acetaminophen
240 Z.A. ALOthman, M.A. Abdallahydrogen sulphide formed can be utilized to produce the violet
colour dye in the degraded solution and this procedure has been
made as the basis of a spectrophotometricmethod of determining
cephalosporins.
On the other hand drugs such as acetaminophen yield p-ami-
no phenol when they are hydrolysed in 5 M sulphuric acid solu-
tion in boiling water-bath. The p-amino phenol formed can be
utilized to produce the red colour dye in the hydrolysed solution
and the method is being used for the determination of p-amino-
phenol and p-amino phenol in pharmaceutical formulations.
The reaction product could be isolated as picrate and per-
chlorate salts and subjected to microanalysis, UV-visible and
IR identiﬁcation tests. A kmax of 505 nm was obtained. The
IR spectrum of both picrate and perchlorate salts of the iso-
lated reaction product of p-aminophenol with the sulphide
ion shows a signiﬁcant difference from that of the pure com-
pound in region of 3500–3100 cm1. The disappearance of
the doublet peaks that are characteristics of a primary amino
group indicates that the nitrogen is a possible reaction site.
In addition, analogous structures have been reported before
for methylene blue and methylene blue like structure (Abdalla
et al., 1982a). From the microanalysis data and the IR spectra
a mechanism for the reaction could be suggested as follows:Studied.
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Table 2 Recommended minimum hydrolysis time (min).
Cephalexin 30
Cephalothin 60
Cephaloridine 60
Cephaxazole 602. Experimental
2.1. Apparatus
A Perkin–Elmer model 330 Spectrophotometer with matching
1.00 cm cell was used for the absorbance measurement.
2.2. Reagents
2.2.1. p-phenylene diamine sulphate solution 0.01 M
Dissolve 0.1 g of p-phenylenediamine sulphate in 1 M sulphu-
ric acid and dilute to 100 ml with 1 M sulphuric acid.
2.2.2. Acetaminophen solution
Dissolve 0.1 g of acetaminophen powder in 20 ml of 5 M sul-
phuric acid.2.2.3. Ammonium iron(III) sulphate. 0.25 M
Dissolve 60.8 g of ammonium iron(III) sulphate dodecahy-
drate in 0.5 M sulphuric acid.
2.2.4. Sodium sulphide solution
Dissolve 1 g of sodium sulphide in 100 ml of water.
Structure of the cephalosporins and acetaminophen studied
are given in Table 1.
2.3. General procedure
Standard cephalosporin solution, 0.1% w/v. Dissolve 0.1 g
(accurately weighed) of cephalosporin in water and dilute to
100 ml in a calibrated ﬂask. Transfer, by means of a pipette, ali-
quots (0–10 ml) of the solutions into a 100 ml calibrated ﬂask
and dilute to volume with 0.5 M sodium hydroxide solution.
Heat the ﬂask in a boiling bath for the length of time appropriate
for the particular cephalosporin to produce maximum yield of
hydrogen sulphide and then cool. Recommended hydrolysis time
of heating can be selected for each cephalosporin from Table 2.
Table 3 Calibration graphs for determination of cephalospo-
rins and acetaminophen in standard solutions.
Compound Concentration
range (lg/ml)
Coeﬃcient
variation (%)
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ﬂask and add 5 ml of the p-phenylenediamine solution and
2 ml of ammonium iron(III) sulphate and quickly stopper
the ﬂask. Shake the ﬂask for 30 s, dilute to mark, mix and read
the absorbance at 595 nm against a blank treated similarly.Cephalexin 5–50 0.76
Cephradine 5–50 0.84
Cephalothin 10–50 0.85
Cephaloridine 10–50 0.77
Cephoxazole 20–100 0.80
Acetaminophen 20–100 0.782.4. For capsules and tablets
Transfer accurately weighed mixed contents of one capsule or
one powdered tablet equivalent to 500 mg of the drug into
50 ml calibrated ﬂask, add 30 ml of methanol, shake for
10 min and then make up to volume with methanol. Filter,
then transfer 50 ml of the ﬁltrate into 50 ml conical ﬂask and
evaporate to dryness. To the residue add 5 ml of water dissolve
and then transfer the contents into 50 ml calibrated ﬂask and
dilute with 0.5 M sodium hydroxide and then complete the as-
say as described above.
For the determination of the acetaminophen in pure form
or in pharmaceutical formulations. Transfer an accurately
weighed mixed content of tablets or its pure powdered form
equivalent to 0.1 g of the drug into a 50 ml calibrated ﬂask
and add 20 ml of 5 M sulphuric acid. Heat the ﬂask in a boiling
water bath for one hour. Cool, then dilute with water. Add by
pipette, 5 ml of each solution to 50 ml calibrated ﬂask and add
5 ml of sodium sulphide and 5 ml of ammonium iron(III) sul-
phate. Shake the ﬂask for 30 s, allow the ﬂask to stand for
5 min. Dilute to mark, mix and read absorbance at 525 nm
against a blank treated similarly.Table 4 Result of the determination of some cephalosporins
and acetaminophen in pharmaceutical formulation.
Drug Nominal composition
(mg)
Found
(mg)
R.S.D.
(%)
Velosef (Squibb) 500 504.1 0.72
250 252.1 0.82
Ultrasporin
(Arab phama Ind)
500 499.2 0.91
250 251.3 0.83
Keﬂodin (Lilly) 500 502.4 0.77
250 251.7 0.75
Prontopyrin (Tablets) 500 503.0 0.78
Saridon (Tablets) 500 502.1 0.67
Calpol (Suspension) 500 502.4 0.71
Table 5 Comparison of results obtained for the determination
of cephalosporins using the proposed method and the B.P.
ofﬁcial method.
Compound Recovery (%)a tb
Proposed method (lg) Oﬃcial method (lg)
Cephalexin 100.3±0.3 101.4±0.3 0.84
Cephradine 101.2±0.2 100.2±0.3 0.88
Cephlothin 99.3±0.2 101.2±0.3 0.85
Cephaloridine 99.7±0.3 102.3±0.2 0.88
Cephoxazole 100.2±0.3 101.2±0.3 0.79
a Means standard deviation for ten determinations.
b Theoretical value = 2.26 at 95% conﬁdence limit.3. Results and discussion
The proposed methods have been used for the quantitative
determination of various cephalosporins and acetaminophen
in pure form and in real sample.
In the ﬁrst method, the sulphide that resulted from the alka-
line degradation of the cephalosporins studied has been re-
acted with p-phenylenediamine and ammonium iron(III)
sulphate as an oxidizing agent to form the violet dye. The
absorbance of the violet dye formed, measured at 595 nm , is
a measure of the cephalosporin concentration. In the second
method, p-aminophenol formed as a result of acid hydrolysis
of acetaminophen has been reacted with sodium sulphide
and iron(III) as oxidizing agent to form the red dye and the
absorbance of the red colour dye formed, measured at
530 nm is a measure of the acetaminophen concentration.
The optimum conditions were studied by variation of the
acidity of the reagent, the concentration of the added reagents
such as ammonium iron(III) sulphate in the ﬁrst method and
the ammonium iron(III) sulphate and the sulphide in the sec-
ond method. In both methods the colour of the dye formed
was dependent on the concentration of sulphuric acid and that
has reached a maximum with 1 M acid in the case of the ﬁrst
method and 2 M acid in the case of the second method. Higher
acidity does not result in greater absorbance in either method.
It is also observed that at higher acidity there is a small shift in
the wavelength of maximum absorbance. Increase in reagent
concentration above 10 ml of either the p-phenylenediamine
or the iron(III) in the ﬁrst method or the iron(III) and the sul-
phide reagents tends to effect the wavelength of the maximum
absorption the same way as with the use of higher acidity. The
absorbance of the violet dye at 423 and the repetitive scanshow that the reaction is completed in 6 min without mixing.
With shaking the colour is developed in 1 min.
3.1. Spectral data
Beer’s law was found to hold over the range 0.1–50 lg/ml for
all the ﬁve cephalosporins examined and over the range 10–
200 lg/ml for the acetaminophen. Table 3 gives data for cali-
bration graphs for the determination of ﬁve cephalosporins
and the acetaminophen. The calibration graphs show good
rectilinearity and low coefﬁcient of variation.
4. Application
The two methods were then applied to the determination of
some cephalosporins and acetaminophen in drug formulations
Table 6 Comparison of results obtained for the determination
of acetaminophen using our method and B.P. ofﬁcial method.
Sample or drug Recovery (%)a tb
Proposed method (lg) Oﬃcial method (lg)
Saridon 101.82 102.1 1.2
Prontopyrin 100.62 100.2 1.3
Calpol 98.88 99.1 1.4
a Means standard deviation for ten determinations.
b Theoretical value = 2.26 at 95% conﬁdence limit.
Table 7 Result of the determination of acetaminophen in
presence of ortho- and meta-aminophenol.
Drug Present (lg) Found SDa Recovery
Saridonc 10 10.22 0.18 102.2
Saridon 10 10.21 0.20 102.1
Prontopyrinb 10 10.31 0.14 103.1
Prontopyrinc 10 10.24 0.17 102.4
a Mean standard deviation for ten determinations.
b With added 5 g of ortho-aminophenol.
c With added 5 g of meta-aminophenol.
242 Z.A. ALOthman, M.A. Abdalla(capsules and tablets). Typical results are given in Table 4. The
results obtained show good agreement with those expected.
The results of the two methods were then compared with
the results obtained by the ofﬁcial method for the cephalospo-
rins and acetaminophen drug as shown in Tables 5 and 6.The
t-test values at 95% conﬁdence limit indicate no signiﬁcant dif-
ferences between these methods. The two methods for the
determination of the cephalosporins and the acetaminophen
have the advantage of using the visible region rather thanthe ultra-violet, where many degradation products and excipi-
ents are usually present in dosage forms, such as starch and
lactose.
The second method that is used for the determination of
acetaminophen is selective and can be used for the determina-
tion of acetaminophen in the presence of ortho- and meta-ami-
nophenol (see Table 7). The method also has the advantage of
being a stability indicating method.
The ﬁrst method, however, has the disadvantages that it is
unlikely to be a stability indicating method and will not distin-
guish between cephalosporins and other sulphide producing
degradation products.
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